Clostridial toxin derivatives able to modify peripheral sensory afferent functions
AssigneesThe Speywood Laboratory Ltd., Microbiological Research Authority
InventorsKeith Alan Foster, Michael John Duggan, Clifford Charles Shone
Life of this patent
Estimating the term…
Abstract
The invention relates to an agent specific for peripheral sensory afferents. The agent may inhibit the transmission of signals between a primary sensory afferent and a projection neuron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent. The agent may be used in or as a pharmaceutical for the treatment of pain, particularly chronic pain.
Claims43
A non-cytotoxic agent which binds to a peripheral sensory afferent which comprises a Targeting Moiety (TM) coupled to a modified clostridial neurotoxin in which the TM comprises a ligand to a cell-surface binding site present on a primary sensory afferent and is capable of functionally interacting with a binding site causing a physical association between the agent and the surface of a primary sensory afferent;
- and the heavy chain (H-chain) of the clostridial neurotoxin is removed or modified by chemical derivitisation, mutation or proteolysis to reduce or remove its native binding affinity for motor neurons;
- and the light chain (L-chain) of the clostridial neurotoxin or a fragment thereof retains a protease activity specific for components of the neurosecretory machinery;
- the TM and the modified H-chain, if present, forming a molecule which introduces the L-chain or fragment thereof into the cytosol of a primary sensory afferent, thereby inhibiting the transmission of signals between a primary sensory afferent and a projection neuron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent.
Dependencies are inferred from the claim text.